Researcher
Erik Van Limbergen
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Radiotherapy (Division)
Member
From1 Oct 2005 → 30 Sep 2018
Publications
131 - 140 of 146
- Prevalent breast cancer patients with a homozygous mutant status for CYP2D6*4: response and biomarkers in tamoxifen users(2009)
Authors: Diether Lambrechts, Bart Claes, Thijs Vandorpe, Hans Wildiers, Dirk Timmerman, Jaak Billen, Frédéric Amant, Ann Smeets, Robert Paridaens, Caroline Weltens, et al.
Pages: 531 - 538 - Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors(2009)
Authors: Vanya Van Belle, Sabine Van Huffel, Frédéric Amant, Ann Smeets, Erik Van Limbergen, Wout Hendrickx, Caroline Weltens, Walter Van den Bogaert, Isabelle Vanden Bempt, Robert Paridaens, et al.
Pages: 349 - 358 - Accelerated partial breast irradiation with intracavitary balloon brachytherapy may be not as simple as it was supposed to be(2009)
Authors: Erik Van Limbergen
Pages: 147 - 149 - Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors(2009)
Authors: Olivier Brouckaert, Saskia Pintens, Vanya Van Belle, Sabine Van Huffel, Edward Camerlynck, Frédéric Amant, Ann Smeets, Karin Leunen, Erik Van Limbergen, Patrick Berteloot, et al.
Pages: 349 - 358 - Lifestyle changes and breast cancer prognosis: a review(2009)
Authors: Eliane Kellen, Greet Vansant, Rose Christiaens, Patrick Neven, Erik Van Limbergen
Pages: 13 - 22 - Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive(2009)
Authors: Ben Van Calster, Isabelle Vanden Bempt, Jiqiu Cheng, Sabine Van Huffel, Wout Hendrickx, Frédéric Amant, Robert Paridaens, Hans Wildiers, Erik Van Limbergen, Caroline Weltens, et al.
Pages: 181 - 187 - Impact of the boost dose in 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial(2009)
Authors: Walter Van den Bogaert, Erik Van Limbergen
Pages: 80 - 85 - Value of Positron Emission Tomography of the Para-Aortic Lymph Nodes in Cervical Carcinoma Stage IB2-IIIB(2008)
Authors: Ignace Vergote, Patrick Neven, Frédéric Amant, Felix Mottaghy, Erik Van Limbergen
Pages: 5654 - 5655 - Radiation-induced sarcoma: analysis of 46 cases(2008)
Authors: Rose Christiaens, Marguerite Stas, Erik Van Limbergen, Ivo De Wever
Pages: 574 - 579 - Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma(2008)
Authors: Marisol De Brabandere, Erik Van Limbergen
Pages: 217 - 226